Exhibit (a) to Form 10-QSB
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 and 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): June 15, 2001
Human Pheromone Sciences, Inc.
------------------------------
(Exact name of Registrant as specified in its charter)
CALIFORNIA 0-23544 94-3107202
---------- ------- ----------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
84 West Santa Clara Street, Suite 720, San Jose, California 95113
- ----------------------------------------------------------- -----
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code: (408) 938-3030
--------------
46750 Fremont Boulevard, Fremont, California 94538
--------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
Exhibit (a) to Form 10-QSB
INFORMATION TO BE INCLUDED IN THE REPORT
ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANTS
The Audit Committee of the Company authorized the termination of
BDO Seidman LLP as auditors of the Company effective June 15, 2001.
The reports of BDO Seidman LLP on the Company's financial
statements for the past two fiscal years did not contain an adverse
opinion or a disclaimer of opinion and were not qualified or
modified as to uncertainty, audit scope, or accounting principles.
In connection with the audits of the Company's financial statements
for each of the two fiscal years ended December 31, 2000, and in
the subsequent interim period through the date hereof, there were
no disagreements with BDO Seidman LLP on any matters of accounting
principles or practices, financial statement disclosure, or
auditing scope and procedures which, if not resolved to the
satisfaction of BDO Seidman LLP would have caused BDO Seidman LLP
to make reference to the matter in their report. The Company has
requested BDO Seidman LLP to furnish it a letter addressed to the
Commission stating whether it agrees with the above statements. A
copy of that letter, dated June 20, 2001, is filed as Exhibit 7.1
to this Form 8-K.
ITEM 7 FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
Exhibit 7.1 - Letter from BDO Seidman LLP pursuant to Item 304 (a)
(3) of Regulation S-K.
Exhibit (a) to Form 10-QSB
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
HUMAN PHEROMONE SCIENCES, INC.
By: /s/ William P. Horgan
------------------------------------------
William P. Horgan, Chief Executive Officer